The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Connected Drug Delivery Devices Market Be By 2030 Compared To Its 2026 Market Size?
The connected drug delivery devices market has experienced significant expansion in recent years. It is projected to grow from $9.27 billion in 2025 to $11.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.8%. This historical growth can be attributed to the increasing adoption of chronic disease management devices, the rising prevalence of diabetes and respiratory disorders, technological advancements in smart syringes and inhalers, growing healthcare digitization initiatives, and heightened awareness concerning medication adherence.
The connected drug delivery devices market is anticipated to show significant expansion in the coming years, with its size projected to reach $27.02 billion in 2030, driven by a compound annual growth rate (CAGR) of 23.9%. This projected growth throughout the forecast period stems from factors such as increasing demand for remote patient monitoring, the broadening of connected healthcare ecosystems, the incorporation of AI-based predictive analytics, the proliferation of wearable drug delivery devices, and supportive government initiatives encouraging digital health adoption. Noteworthy trends during this period are expected to include personalized medication adherence monitoring, advanced remote patient monitoring solutions, integration with electronic health records (EHR), data-driven dose optimization, and the provision of real-time alerts and notifications.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp
Which Strong Drivers Are Impacting The Connected Drug Delivery Devices Market Growth?
The growing significance of remote patient monitoring is anticipated to drive the expansion of the connected drug delivery device market in the future. This healthcare delivery method employs technology to remotely track patient health and medical information. Connected drug delivery devices enhance remote patient monitoring by enabling accurate tracking of medication usage and adherence, facilitating timely interventions, and providing personalized care management. For instance, in May 2024, the Journal of Medical Internet Research, a Canada-based peer-reviewed journal, reported that 38.78% of US adults had utilized telehealth services in the past year. Consequently, the rising prominence of remote patient monitoring is fueling the development of the connected drug delivery device market.
How Are Different Segments Classified In The Connected Drug Delivery Devices Market Segment Analysis?
The connected drug delivery devices market covered in this report is segmented –
1) By Type: Standalone Components And Software, Integrated Devices
2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies
3) By Administration: Parenteral, Inhalational
4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications
Subsegments:
1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software
2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices
Which Trends Are Guiding The Direction Of The Connected Drug Delivery Devices Market?
Leading firms within the **connected drug delivery devices market** are prioritizing the introduction of sophisticated, durable, and highly integrated digital health solutions designed to boost treatment ease, refine monitoring precision, and facilitate smooth interaction with automated therapy systems. For instance, **Dexcom**, a healthcare company based in the **US**, announced in **November 2025** the launch of its new **G7 15 Day** continuous glucose monitor in the **U.S.** for **adults with diabetes**, effective **December 1, 2025**. This device, recently cleared by the FDA, will be the longest-wearing CGM offered, providing usage for up to **15.5 days** and featuring an enhanced MARD accuracy of **8%**. Upon its release, it will be accessible via DME providers and eligible for **Medicare** beneficiaries. The upgraded sensor is compatible with the **iLet Bionic Pancreas**, **Omnipod 5**, and future **Tandem** pumps, in addition to supporting **Dexcom’s** novel **Smart Basal** insulin optimization system. Offering reduced sensor replacements, a waterproof construction, connectivity with smartwatches, and streamlined logging capabilities, the **G7 15 Day** intends to provide enhanced user convenience and superior long-term glucose control.
Who Are The Companies Driving Activity In The Connected Drug Delivery Devices Market?
Major companies operating in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, Findair Sp. z.o.o, Omron Healthcare Co. Ltd, Omnicell Inc., BD Medical
Get The Full Connected Drug Delivery Devices Market Report:
Which Region Leads The Connected Drug Delivery Devices Market In Overall Market Size?
North America was the largest region in the connected drug delivery market in 2025. The regions covered in the connected drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Connected Drug Delivery Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Connected Drug Delivery Devices Market 2026, By The Business Research Company
Connected Drug Delivery Devices Market Report 2026
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model